GENE ONLINE|News &
Opinion
Blog

Phase III
ESMO 2024 Prostate CancerBayer
Bayer’s NUBEQA: Breakthrough in Prostate Cancer with 46% Risk Reduction and Future FDA Expansion Plans
2024-09-19
Ranking & Reports Financemarket insights
Alnylam Pharma Shares Dip Despite Positive Phase 3 HELIOS-B Heart Disease Results
2024-09-04
Interviews AusBiotech
AusBiotech on Funding, Regulatory Navigation, International Expansion, and Clinical Trial Development in Australia’s Biotech Industry
2024-08-22
Pneumococcal Vaccine
SK Bioscience and Sanofi Advance Global Phase III Study for Pneumococcal Conjugate Vaccine
2023-12-11
LATEST
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Norwegian Stakeholders Identify Implementation Challenges in Elder Abuse Prevention Guidelines for 2026 BMC Geriatrics Study
2026-07-11
Biotech Stock Performance Gap Widens During Second Quarter of 2026
2026-07-11
PYGO2 Overexpression Linked to Increased Plasma Cell Proliferation in Multiple Myeloma Patients with 1q21 Amplification
2026-07-10
Sean Kaufman Faces Senate Scrutiny Over Past Vaccine Safety Comments Ahead of Confirmation Hearing
2026-07-10
Penn State College of Medicine Receives $2.5 Million Grant for Street Medicine Program
2026-07-10
IBEC and European Researchers Receive Novo Nordisk Foundation Grant to Study Physics of Living Matter
2026-07-10
READ MORE
EVENT
2026-07-08
ISSCR (Regenerative Medicine &Cell Therapy)
Montreal, Canada
2026-07-15
BIO Asia-Taiwan 2026 (APAC Biotech & Investment)
Taipei, Taiwan
2026-08-07
Healthy Ageing Tech Show (7-9 Aug, TAIPEI WTC) (Longevity, elder care & ageing tech)
Taipei, Taiwan
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
SEE MORE
Scroll to Top